Multiple antigen specific cell therapy methods
US11248208B2 · kind B2 · utility
2Cited by
9References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2019 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Mar 29, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1121
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of preparing a population of activated T cells by co-culturing T cells with dendritic cells loaded with a plurality of tumor antigen peptides. Also provided are methods of treating cancer in an individual using the activated T cells, pharmaceutical compositions and kits for cell-based cancer immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.